Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-11-27Clinical Trial Update: A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males [Phase 1]
Phase 1 study to assess the pharmacoMRI effects of AUT00206 in healthy male volunteers. Schizophrenia is listed as a related condition in th…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia [NA]
Clinical trial of Withania Somnifera as an immunomodulator and anti-inflammatory agent for schizophrenia and schizoaffective disorder has co…
-
CLINICAL_TRIALS research · 2017-11-21Clinical Trial Update: A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia [Phase 1]
Phase 1 multiple-dose study of ABT-288 in stable subjects with schizophrenia to evaluate safety, tolerability, pharmacokinetics, and pharmac…
-
FDA approval · 2017-11-17FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc. for the generic product (ANDA201824).
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Evaluation of Metamemory in Patients With Schizophrenia [NA]
This document reports the completion status of a clinical trial evaluating metamemory in patients with schizophrenia; aging is listed as a r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia [Phase 2]
A Phase 2 trial evaluating a galantamine and memantine combination for cognitive impairments in schizophrenia was terminated, with results p…
-
CLINICAL_TRIALS research · 2017-11-07Clinical Trial Update: Perceptual Deficits in Schizophrenia [NA]
Clinical trial update on perceptual deficits in schizophrenia and schizoaffective disorder; the status is listed as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A System for Preference Assessment in Mental Health [NA]
A UCLA-run clinical trial update describes a system for preference assessment in mental health. The listed conditions include mental disorde…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Oxytocin and CBSST for People With Schizophrenia [NA]
Clinical trial update for oxytocin and CBSST in schizophrenia and schizoaffective disorder has completed with results posted in 2017.
-
CLINICAL_TRIALS research · 2017-10-26Clinical Trial Update: Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care. [NA]
This clinical trial evaluates the use of joint crisis plans or crisis cards to reduce coercion in psychiatric care for people with schizophr…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment. [Phase 2]
A completed Phase 2 study evaluating four doses of BI 409306 versus placebo over 12 weeks in schizophrenia patients on stable antipsychotic …
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: The Partners Genetics Collaborative Study of Schizophrenia
Clinical trial update noting completion of the Partners Genetics Collaborative Study of Schizophrenia, sponsored by Massachusetts General Ho…
-
CLINICAL_TRIALS research · 2017-10-19Clinical Trial Update: "Manual Dexterity and Oculomotor Control in Schizophrenia" [NA]
Update on a schizophrenia clinical trial evaluating manual dexterity and oculomotor control; the current trial status is unknown.
-
FDA approval · 2017-10-17FDA Approved: FLUPHENAZINE DECANOATE — Original Application (Eugia US LLC)
FDA approved an original ANDA for fluphenazine decanoate, a long-acting injectable antipsychotic.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride [Phase 1]
Phase 1 study assessing intra-subject variability in the bioavailability of chlorpromazine hydrochloride. The study is completed and results…
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients [Phase 4]
Phase 4 clinical trial examining the relationship between clozapine plasma levels and genetic polymorphisms in patients with schizophrenia; …
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia
A National Institute of Mental Health-sponsored clinical trial evaluating genetic risk factors for childhood-onset schizophrenia has been te…
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Screening for Childhood-Onset Psychotic Disorders
The NIMH-sponsored screening trial for childhood-onset psychotic disorders has been terminated; the update does not report results.
-
CLINICAL_TRIALS research · 2017-10-09Clinical Trial Update: Visual Information Processing in Schizophrenia Patients With Visual Hallucinations [NA]
A clinical trial update focusing on visual information processing in schizophrenia patients with visual hallucinations; the trial status is …
-
CLINICAL_TRIALS trial_result · 2017-10-05Clinical Trial Update: Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia [Phase 4]
Pilot Phase 4 trial evaluating atomoxetine to enhance cognition in schizophrenia; completed.
-
CLINICAL_TRIALS trial_result · 2017-10-04Clinical Trial Update: Improving Outcomes for Individuals With Serious Mental Illness and Diabetes [NA]
Clinical trial update on improving outcomes for individuals with serious mental illness and diabetes; study completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia [Phase 2]
Phase 2 study results for TAK-063 in acute exacerbation of schizophrenia have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia [Phase 4]
Phase 4 clinical trial update on modafinil for cognitive dysfunction in schizophrenia and schizoaffective disorder; study completed with res…
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Modafinil Effects on Cognition in Schizophrenia Patients [Phase 4]
Phase 4 clinical trial investigating modafinil effects on cognition in schizophrenia has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-27Clinical Trial Update: Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia [Phase 2]
Phase 2 trial evaluated efficacy and safety of GSK239512 in schizophrenia. The study is completed and results were posted in 2017.